A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide.
about
Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models: the experience with 5,6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug eliminated mainly by conjugation.Effective immunomodulatory treatment of Escherichia coli experimental sepsis with thalidomide.Pharmacokinetic evaluation of vadimezan (ASA404, 5,6-dimethylxanthenone-4-acetic acid, DMXAA).
P2860
A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A difference between the rat a ...... -acetic acid with thalidomide.
@en
A difference between the rat a ...... -acetic acid with thalidomide.
@nl
type
label
A difference between the rat a ...... -acetic acid with thalidomide.
@en
A difference between the rat a ...... -acetic acid with thalidomide.
@nl
prefLabel
A difference between the rat a ...... -acetic acid with thalidomide.
@en
A difference between the rat a ...... -acetic acid with thalidomide.
@nl
P2093
P356
P1476
A difference between the rat a ...... -acetic acid with thalidomide.
@en
P2093
P2888
P304
P356
10.1007/S002800100285
P577
2001-06-01T00:00:00Z
P5875
P6179
1052888073